A locus for Peutz-Jeghers syndrome (PJS) was recently mapped to chromosome l9pl3.3. Each of 12 families studied was compatible with linkage to the marker D19S886. We have analysed 20 further families and found that the majority of these are consistent with a PJS gene on l9pl3.3. Three families were, however, unlinked to l9pI3.3 and none of the available PJS polyps from these families showed allele loss at D19S886. There were no obvious clinicopathological or ethnic differences between the 19pl3.3 linked and unlinked families. There appears, therefore, to be a major PJS locus on chromosome l9pl3.3 and the possibility exists of a minor locus (or loci) elsewhere. (JMed Genet 1998;35:42-44) 
Peutz-Jeghers syndrome (PJS) is a dominantly inherited disease of hamartomatous gastrointestinal polyps and mucocutaneous pigmentation of the lips, buccal mucosa, axillae, fingers, and toes.' PJS predisposes to cancers of several sites (gastrointestinal tract, ovary, testis, endometrium, and breast). The PJS locus may therefore have a role in many sporadic cancers, as has the PTEN gene which is implicated in Cowden's disease and mutated in sporadic prostate and breast cancers and in some brain tumours. '' A PJS locus has recently been mapped to chromosome l9pl3.3.4 A candidate site for a PJS gene was initially discovered using comparative genomic hybridisation (CGH) in PJS polyps. CGH detected deletions in polyps from a single PJS patient towards the telomere of chromosome 19p, suggesting that the PJS gene acted as a tumour suppressor. After microdissection of the polyps, this region was confirmed as a site of allele loss using microsatellite markers and the allele derived from the unaffected parent was consistently lost. Twelve families were then studied by linkage analysis, producing a combined two point lod score at D19S886 (the most telomeric marker on the Genethon genetic map) of 5 also obtained. Samples of peripheral blood (10 ml) were taken from subjects useful for linkage analysis and DNA was extracted using standard methods. These subjects were genotyped at the D19S886, D19S878, and D19S565 microsatellite loci which map close to the telomere of chromosome l9p. A total of 50 ng of genomic DNA was amplified using the PCR in 25 pl of 75 mmol/l Tris-HCl (pH 9), 0.0 1% (v/v) Tween, 1.5 mmol/l MgCl2, 0.25 U Taq polymerase, 20 mmol/l (NH4)2S04, 0.1% (w/v) BSA, 0.2 mmol/l each dNTP and each primer at 5 ng/pil. One primer had previously been end labelled with y'2ATP using 3 U of T4 polynucleotide kinase. Thirty-five cycles of the PCR were carried out at 94°C for one minute, 55°C for one minute, and 72°C for one minute with a final extension step at 72°C for 10 minutes. The products were electrophoresed through 6% denaturing polyacrylamide gels, dried, and exposed to x ray film for 24 hours.
Linkage analysis was performed using the MLINK program. PJS was modelled as a rare dominant trait (q=0.0001) with high penetrance (80%) and no phenocopies. Marker allele frequencies were estimated from pedigree founders. The order of and distances between the markers were based on the current Genethon map. Genetic heterogeneity was tested using the HOMOG program. Nevertheless, the existence of three families unlinked to D19S886 in this study provides evidence that there is a second, minor PJS locus (or even more than one additional PJS locus).
Peutz-_Jeghers disease
It is almost certain that each of the 19p unlinked families has PJS rather than another hamartomatous disease such as juvenile polyposis, as the histology of polyps from these families has been checked by several independent pathologists. The failure to observe allele loss at D19S886 or D19S878 in polyps from two of the 1 9p unlinked families (even allowing for the fact that some cases will have small scale mutations and for problems of contaminating stroma) fails to provide any support for linkage of these families' disease to l9p13.3. Misdiagnosis of polyps or pigmentation in certain critical subjects from the families unlinked to l9p 13.3 does, however, remain a possibility, although all patients were under the care of specialist clinicians. For this explanation to be correct, a minimum of the following would have to have been misdiagnosed as affected: subject 4815 (family G842) with pigmentation only; subject 376 (family G199) with polyps and pigmentation; and subject 3986 (family G69) with polyps and pigmentation. In addition, non-penetrance ofthe disease allele would have to have occurred in three or four people.
If there is a second PJS locus, where might it be? The first good candidate sites for a PJS locus were the chromosomal breakpoints in a patient with a pericentric inversion of chromosome 6 and PJS.5 Haplotype inspection (details not shown) in the three families unlinked to l9pl 3.3 shows that the disease is not linked to markers at either of the breakpoint sites, or to the site of the maximum lod score on chromo- 
